J9集团

EN
×
mo_logo sv2on EN
cbl8
cbl15
logocbl cblclose
  • 业务征询

    中国:

    Email: marketing@medicilon.com.cn

    业务征询专线:400-780-8018

    (仅限服务征询,其他事宜请拨打川沙总部电话)

    川沙总部电话: +86 (21) 5859-1500

    海表:

    +1(781)535-1428(U.S.)

    0044 7790 816 954 (Europe)

    Email:marketing@medicilon.com

61149122d2629
zxly
cbl16
在线留言×
点击切换
guanbi
banner
Customer Center
客户中心

放射疗法用作肺癌的重要医治步骤,本钻研中成立抗电离辐射肺癌细胞系的放射医治通过J9集团进行

业务征询

2023-06-28
|
接见量:

13-A549-IR-1.jpg

Radiation therapy is used as the primary treatment for lung cancer. In this study, radiation therapy for establish ionizing radiation-resistant lung cancer cell lines (A549-IR/H1299-IR) was supported by Medicilon

The A549 and H1299 cells in exponential growth phase were treated with a repeated IR dose of 2 Gy each at room temperature and then returned to the incubator.

Reference

Kan Wu, et al. Capilliposide C from Lysimachia capillipes Restores Radiosensitivity in Ionizing Radiation-Resistant Lung Cancer Cells Through Regulation of ERRFI1/EGFR/STAT3 Signaling Pathway. Front Oncol. 2021 Apr 1;11:644117. doi: 10.3389/fonc.2021.644117.

new30有关新闻
×
搜索验证
点击切换
【网站地图】